FOXM1c is activated by cyclin E/Cdk2, cyclin A/Cdk2, and cyclin A/Cdk1, but repressed by GSK-3α

Biochemical and Biophysical Research Communications

Volumn 348, Issue 1, 2006, Pages 99-108

  Wierstra, Inken ^a   Alves, Jürgen ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cyclin A Cdk1; Cyclin A Cdk2; Cyclin E Cdk2; FOXM1c; GSK 3 ; Transcription factor

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN E; GLYCOGEN SYNTHASE KINASE 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXM1; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME REPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; TRANSACTIVATION;

CYCLIN A; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FORKHEAD TRANSCRIPTION FACTORS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS);

EID: 33746780589     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.07.008     Document Type: Article

References (44)

1. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13 (1999) 1501-1512
2. Sherr C.J., and McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2 (2002) 103-112
3. Sherr C.J., and Roberts J.M. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 18 (2004) 2699-2711
4. Obaya A.J., and Sedivy J.M. Regulation of cyclin-Cdk activity in mammalian cells. Cell. Mol. Life Sci. 59 (2002) 126-142
5. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 81 (1995) 323-330
6. Pardee A.B. G1 events and regulation of proliferation. Science 246 (1989) 603-608
7. Adams P.D. Regulation of the retinoblastoma tumor suppressor protein by cyclin/Cdks. Biochim. Biophys. Acta 1471 (2001) M123-M133
8. Cobrinik D. Pocket proteins and cell cycle control. Oncogene 24 (2005) 2796-2809
9. Ezhevsky S.A., Nagahara H., Vocero-Akbani A.M., Gius D.R., Wei M.C., and Dowdy S.F. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclinD-Cdk4/6 complexes results in active pRb. Proc. Natl. Acad. Sci. USA 94 (1997) 10699-10704
10. Harbour J.W., Luo R.X., Dei Santi A., Postigo A.A., and Dean D.C. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98 (1999) 859-869
11. Harbour J.W., and Dean D.C. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14 (2000) 2393-2409
12. Lundberg A.S., and Weinberg R.A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-CDK complexes. Mol. Cell. Biol. 18 (1998) 753-761
13. Korver W., Roose J., and Clevers H. The winged-helix transcription factor Trident is expressed in cycling cells. Nucleic Acids Res. 25 (1997) 1715-1719
14. Kalinichenko V.V., Gusariva G.A., Tan Y., Wang I.C., Major M.L., Wang X., Yoder H.M., and Costa R.H. Ubiquitous expression of the Forkhead Box M1B transgene accelerates proliferation of distinct pulmonary cell types following lung injury. J. Biol. Chem. 39 (2003) 37888-37894
15. CIP1/WAF1 levels and accelerates mouse hepatocyte entry into S-phase following carbon tetrachloride liver injury. Hepatology 33 (2001) 1404-1414
16. Wang X., Kiyokawa H., Dennewitz M.B., and Costa R.H. The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc. Natl. Acad. Sci. USA 99 (2002) 16881-16886
17. Ye H., Holterman A.X., Yoo K.W., Franks R.R., and Costa R.H. Premature expression of the winged helix transcription factor HFH-11B in regenerating mouse liver accelerates hepatocyte entry into S-phase. Mol. Cell. Biol. 19 (1999) 8570-8580
18. Laoukili J., Kooistra M.R.H., Brás A., Kauw J., Kerkhoven R.M., Morrison A., Clevers H., and Medema R.H. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat. Cell Biol. 7 (2005) 126-136
19. Ma R.Y., Tong T.H., Cheung A.M., Tsang A.C., Leung W.Y., and Yao K.M. Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c. J. Cell. Sci. 118 (2005) 795-806
20. Korver W., Schilham M.W., Moerer P., van den Hoff M.J., Lamers W.H., Medema R.H., and Clevers H. Uncoupling of S phase and mitosis in cardiomyocytes and hepatocytes lacking the winged-helix transcription factor Trident. Curr. Biol. 8 (1998) 1327-1330
21. ARF tumor suppressor. Genes Dev. 18 (2004) 830-850
22. Kalin T.V., Wang I.C., Ackerson T.J., Major M.L., Detrisac C.J., Kalinichenko V.V., Lyubimov A., and Costa R.H. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res. 66 (2006) 1712-1720
23. Kim I.M., Ackerson T., Ramakrishna S., Tretiakova M., Wang I.C., Kalin T.V., Major M.L., Gusarova G.A., Yoder H.M., Costa R.H., and Kalinichenko V.V. The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res. 66 (2006) 2153-2161
24. Wang I.C., Chen Y.J., Hughes D., Petrovic V., Major M.L., Park H.J., Tan Y., Ackerson T., and Costa R.H. Forkhead Box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol. Cell. Biol. 25 (2005) 10875-10894
25. Wonsey D.R., and Follettie M.T. Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res. 65 (2005) 5181-5189
26. Major M.L., Lepe R., and Costa R.H. Forkhead Box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300/CBP coactivators. Mol. Cell. Biol. 24 (2004) 2649-2661
27. Lüscher-Firzlaff J.M., Westendorf J.M., Zwicker J., Burkhardt H., Henriksson M., Müller R., Pirollet F., and Lüscher B. Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation. Oncogene 18 (1999) 5620-5630
28. Lüscher-Firzlaff J.M., Lilischkis R., and Lüscher B. Regulation of transcription factor FOXM1c by Cyclin E/CDK2. FEBS Lett. 580 (2006) 1716-1722
29. Pilarsky C., Wenzig M., Specht T., Saeger H.D., and Grutzmann R. Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia 6 (2004) 744-750
30. Wierstra I., and Alves J. Despite its strong transactivation domain transcription factor FOXM1c is kept almost inactive by two different inhibitory domains. Biol. Chem. 387 (2006) 963-976
31. Wierstra I., and Alves J. Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4. Biol. Chem. 387 (2006) 949-962
32. Firzlaff J.M., Lüscher B., and Eisenman R.N. Negative charge at the casein kinase II phosphorylation site is important for transformation but not for Rb binding by the E7 protein of human papillomavirus type 16. Proc. Natl. Acad. Sci. USA 88 (1991) 5187-5191
33. Chen C.A., and Okayama H. Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 6 (1988) 632-638
34. Bousset K., Oelgeschläger M., Henriksson M., Schreek S., Burkhardt H., Litchfield D.W., Lüscher-Firzlaff J.M., and Lüscher B. Regulation of transcription factors c-Myc, Max and c-Myb by casein kinase II, Cell. Mol. Biol. Res. 40 (1994) 501-511
35. Larsson L.G., Bahram F., Burkhardt H., and Lüscher B. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells. Oncogene 15 (1997) 737-748
36. Ye H., Kelly T.F., Samadani U., Lim L., Rubio S., Overdier D.G., Roebuck K.A., and Costa R.H. Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol. Cell. Biol. 17 (1997) 1626-1641
37. Logan C.Y., and Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20 (2004) 781-810
38. Lawlor M.A., and Alessi D.R. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?. J. Cell Sci. 114 (2001) 2903-2910
39. Patel S., Doble B., and Woodgett J.R. Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword?. Biochem. Soc. Trans. 32 (2004) 803-808
40. Jope R.S., and Johnson G.V.W. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29 (2004) 95-102
41. Doble B.W., and Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116 (2003) 1175-1186
42. Cully M., You H., Levine A.J., and Mak T.W. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer 6 (2006) 184-192
43. Kitagawa M., Higashi H., Jung H.K., Suzuki-Takahashi I., Ikeda M., Tamai K., Kato J.Y., Segawa K., Yoshida E., Nishimura S., and Taya Y. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15 (1996) 7060-7069
44. Nigg E.A. Targets of cyclin-dependent protein kinases. Curr. Opin. Cell Biol. 5 (1993) 187-193